Pharmafile Logo
Pharmafocus logo
Advanced Search

Vaccine

Showing 13 posts of 283 posts found.

Sanofi image

Setback for Sanofi dengue vaccine

September 13, 2012
Research and Development, Sales and Marketing Dengue fever, Sanofi, Sanofi Pasteur, Vaccine

Sanofi Pasteur’s vaccine for dengue fever has failed to show protection against a key serotype of the potentially fatal illness. …

News
immatics image

immatics’ vaccine increases survival in kidney cancer

July 30, 2012
Research and Development, Sales and Marketing IMA901, Vaccine, Yervoy, immatics, phase III

immatics’ investigational cancer vaccine has increased survival rates in patients with renal cell carcinoma. In a late-stage trial, the German …

News

GSK faces fine over Argentina clinical trial

January 6, 2012
Research and Development, Sales and Marketing Argentina, GSK, Vaccine, deaths, emerging markets

A court in Argentina says GSK should be fined for irregularities in recruitment during a trial in which children died. …

News

Novartis submits meningococcal vaccine Bexsero for European approval

December 23, 2010
Sales and Marketing Bexsero, MenB, Novartis, Vaccine, bacterial meningitis, bloodstream infection sepsis, meningococcal disease, meningococcal vaccine

Novartis has submitted its meningococcal vaccine Bexsero to European regulators for marketing approval. If approved the drug will be the …

News

GSK shingles vaccine enters late stage trials

August 23, 2010
Research and Development, Sales and Marketing GSK, Vaccine, shingles

GlaxoSmithKline has started enrollment for phase III trials for its herpes zoster vaccine for the prevention of shingles. The trials …

News

FDA backs rotavirus vaccine despite contamination

May 13, 2010
Sales and Marketing GSK, Rotavirus, Vaccine, drug safety, rotarix

FDA advisors have recommended two rotavirus vaccines licensed in the US should continue to be used, despite contamination with a …

News
Vaccination

Cheaper vaccines for developing countries

March 24, 2010
Vaccine, developing world, vaccines

GlaxoSmithKline and Pfizer have signed a deal to supply anti-pneumococcal drugs to developing countries at steeply discounted prices. GSK will …

News

Virus contamination found in GSK’s Rotarix

March 23, 2010
Business Services, Manufacturing and Production, Sales and Marketing Contamination, GSK, Vaccine, manufacturing compliance

The European Medicines Agency has demanded more information “as a matter of urgency” from GlaxoSmithKline over a virus in its …

News

WHO suspends use of Sanofi-Aventis vaccine

March 18, 2010
Manufacturing and Production Sanofi-Aventis, Shantha Biotechnics, Vaccine

The World Health Organization has temporarily stopped procurement and use of a combination vaccine supplied by Sanofi-Aventis subsidiary Shantha Biotechnics …

News

Pandemic planning: GSK’s Dr Neil Formica

September 1, 2009
Research and Development GlaxoSmithKline, Vaccine, h1n1

 

Feature
GSKfluvaccine

Racing to save lives and fighting the PR battle

August 6, 2009
Medical Communications, Research and Development Vaccine, clinical trials, public relations

Vaccine companies are working round the clock to develop and manufacture a vaccine for the H1N1 pandemic flu, and are …

Feature

Mexican flu: contained but not beaten

May 21, 2009
Research and Development Mexico, Vaccine, flu, pandemic

Global efforts to limit the impact of the new strain of H1N1 flu virus have proven successful, but the threat …

Feature

Novartis vaccine recalled after contamination scare

February 26, 2009
Manufacturing and Production, Research and Development Vaccine

Novartis has recalled UK supplies of its meningitis C vaccine after tests found some batches contaminated with bacteria. The recall …

News

Latest content

AbbVie invests €150m in new R&D facility in Germany

May 3, 2024

AstraZeneca shares positive interim results from phase 3 lymphoma trial

May 3, 2024

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024